Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rix

Showing results (621-630 of 837) with videos related to

Pageof 84
Sort By:
Oncotarget|June 17, 2014
Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformationHua Yang, Harshani R Lawrence, Aslamuzzaman Kazi, et al.
Archives of Internal Medicine|September 27, 2006
Improved therapeutic monitoring with several interventions: a randomized trialAdrianne C Feldstein, David H Smith, Nancy Perrin, et al.
Plos One|June 17, 2021
CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell linesGabriela M Wright, Nick T Gimbrone, Bhaswati Sarcar, et al.
Molecular Cell|August 20, 2005
Structural basis for the cytoskeletal association of Bcr-Abl/c-AblOliver Hantschel, Silke Wiesner, Thomas Güttler, et al.
Transplantation Proceedings|February 6, 2007
Donor risk factors for renal graft thrombosisA Sanni, C H Wilson, H Wyrley-Birch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinibOliver Hantschel, Uwe Rix, Uwe Schmidt, et al.
Microbiome|February 15, 2021
Subcellular view of host-microbiome nutrient exchange in sponges: insights into the ecological success of an early metazoan-microbe symbiosisMeggie Hudspith, Laura Rix, Michelle Achlatis, et al.
The Journal of Vascular Access|December 29, 2007
Survival of arteriovenous fistula for dialysis at different centers in the North of EnglandP C Shrestha, J Asher, S M Shrestha, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2021
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis toolBenjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 3, 2010
Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosisMohammed Sanjak, Francois Salachas, Elizabeth Frija-Orvoen, et al.
Pageof 84

Showing results (621-630 of 837) with videos related to

Sort By:
Pageof 84
Oncotarget|June 17, 2014
Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformationHua Yang, Harshani R Lawrence, Aslamuzzaman Kazi, et al.
Archives of Internal Medicine|September 27, 2006
Improved therapeutic monitoring with several interventions: a randomized trialAdrianne C Feldstein, David H Smith, Nancy Perrin, et al.
Plos One|June 17, 2021
CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell linesGabriela M Wright, Nick T Gimbrone, Bhaswati Sarcar, et al.
Molecular Cell|August 20, 2005
Structural basis for the cytoskeletal association of Bcr-Abl/c-AblOliver Hantschel, Silke Wiesner, Thomas Güttler, et al.
Transplantation Proceedings|February 6, 2007
Donor risk factors for renal graft thrombosisA Sanni, C H Wilson, H Wyrley-Birch, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2007
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinibOliver Hantschel, Uwe Rix, Uwe Schmidt, et al.
Microbiome|February 15, 2021
Subcellular view of host-microbiome nutrient exchange in sponges: insights into the ecological success of an early metazoan-microbe symbiosisMeggie Hudspith, Laura Rix, Michelle Achlatis, et al.
The Journal of Vascular Access|December 29, 2007
Survival of arteriovenous fistula for dialysis at different centers in the North of EnglandP C Shrestha, J Asher, S M Shrestha, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2021
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis toolBenjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 3, 2010
Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosisMohammed Sanjak, Francois Salachas, Elizabeth Frija-Orvoen, et al.
Pageof 84